Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05121493 · ClinicalTrials.gov registry record · NA
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
A NA study, sponsored by University of Rochester.
- Not yet
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05121493 is a NA study that has not yet begun recruiting, run by University of Rochester. The registered enrollment target is 15 participants.
The verdict
NCT05121493, a NA study, has not yet begun recruiting, sponsored by University of Rochester.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to determine if using platelet rich plasma drops can improve clinically significant dry eye in patients and determine if there is a difference with using two different uses of the plasma tear drops: platelet rich plasma tears and plasma tears without platelets.
Interventions
- OTHER Platelet Poor Plasma Tear Drops
- OTHER Platelet Rich Plasma Tear Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05121493
The ClinicalTrials.gov registry entry for NCT05121493 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet Poor Plasma Tear Drops is the first listed.
NCT05121493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05121493 about?
NCT05121493 is a clinical study titled "Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye". This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to determine if using platelet rich plasma drops can improve clinically significant dry eye in patients and ...
What is the current status of trial NCT05121493?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-10-15. Estimated completion is 2026-12-15.
What interventions are being tested in trial NCT05121493?
The interventions under investigation include: Platelet Poor Plasma Tear Drops (OTHER), Platelet Rich Plasma Tear Drops (OTHER).
Who is sponsoring clinical trial NCT05121493?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.